SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,221 | -24.5% | 45,636 | -3.7% | 0.00% | -33.3% |
| Q1 2024 | $1,617 | +14.8% | 47,395 | -2.6% | 0.00% | 0.0% |
| Q4 2023 | $1,409 | +2.3% | 48,682 | -2.5% | 0.00% | 0.0% |
| Q3 2023 | $1,377 | -12.1% | 49,942 | -4.2% | 0.00% | -25.0% |
| Q2 2023 | $1,567 | -19.3% | 52,113 | -2.7% | 0.00% | -20.0% |
| Q1 2023 | $1,941 | -1.9% | 53,572 | -3.4% | 0.01% | 0.0% |
| Q4 2022 | $1,978 | -99.9% | 55,450 | +0.3% | 0.01% | 0.0% |
| Q3 2022 | $1,872,000 | +23.3% | 55,299 | +5.4% | 0.01% | +25.0% |
| Q2 2022 | $1,518,000 | +8.5% | 52,475 | +21.2% | 0.00% | +33.3% |
| Q1 2022 | $1,399,000 | +10.9% | 43,293 | +0.0% | 0.00% | +50.0% |
| Q4 2021 | $1,262,000 | +10.1% | 43,279 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $1,146,000 | -14.2% | 42,958 | -0.9% | 0.00% | -33.3% |
| Q2 2021 | $1,335,000 | +17.3% | 43,343 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $1,138,000 | +3.7% | 43,474 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $1,097,000 | +20.5% | 43,609 | -0.1% | 0.00% | +50.0% |
| Q3 2020 | $910,000 | -12.8% | 43,668 | -0.7% | 0.00% | -33.3% |
| Q2 2020 | $1,044,000 | +32.0% | 43,969 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $791,000 | -20.2% | 43,969 | +5.3% | 0.00% | 0.0% |
| Q4 2019 | $991,000 | -13.4% | 41,774 | +0.2% | 0.00% | -25.0% |
| Q3 2019 | $1,145,000 | -15.7% | 41,674 | +1.5% | 0.00% | 0.0% |
| Q2 2019 | $1,358,000 | -2.9% | 41,046 | +2.8% | 0.00% | 0.0% |
| Q1 2019 | $1,399,000 | +13.6% | 39,938 | +7.7% | 0.00% | 0.0% |
| Q4 2018 | $1,232,000 | -32.5% | 37,084 | +2.2% | 0.00% | -33.3% |
| Q3 2018 | $1,826,000 | -14.2% | 36,269 | +2.1% | 0.01% | -14.3% |
| Q2 2018 | $2,127,000 | +33.9% | 35,532 | +2.5% | 0.01% | +40.0% |
| Q1 2018 | $1,588,000 | +25.7% | 34,672 | +9.4% | 0.01% | +25.0% |
| Q4 2017 | $1,263,000 | +1.6% | 31,705 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $1,243,000 | -5.0% | 31,080 | +2.4% | 0.00% | -20.0% |
| Q2 2017 | $1,308,000 | +48.6% | 30,340 | +7.9% | 0.01% | +25.0% |
| Q1 2017 | $880,000 | +32.5% | 28,130 | +7.0% | 0.00% | +33.3% |
| Q4 2016 | $664,000 | +5.7% | 26,280 | +3.5% | 0.00% | 0.0% |
| Q3 2016 | $628,000 | +79.4% | 25,390 | +48.0% | 0.00% | +50.0% |
| Q2 2016 | $350,000 | +50.2% | 17,160 | +12.4% | 0.00% | +100.0% |
| Q1 2016 | $233,000 | +17.1% | 15,270 | +3.0% | 0.00% | 0.0% |
| Q4 2015 | $199,000 | – | 14,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |